Alzamend Neuro (ALZN) Payables (2020 - 2026)
Alzamend Neuro (ALZN) posted Payables of $2.74 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), up 178.6% from $983,311 a year earlier and up 103.5% from the prior quarter.
Alzamend Neuro (ALZN) Payables (2020 - 2026) Analysis & Trends
At the end of FY2026 (ended Apr 30, 2026), Alzamend Neuro's Payables came in at $1.35 million, up 112.1% from FY2025.
- Annual Payables shows a five-year compound annual growth rate of 21.7% (FY2021 to FY2026).
- In prior fiscal years, Alzamend Neuro's Payables was $634,761 in FY2025 (-80.3%), $3.23 million in FY2024 (+12.4%), $2.87 million in FY2023 (+146.8%) and $1.16 million in FY2022 (+130.9%).
- The fiscal Q1 2027 figure stands as the highest quarterly Payables since fiscal Q1 2025.
- On a year-over-year basis, Payables has increased in each of the last three quarters, with growth averaging 13.8% over the last eight quarters.
- The strongest year-over-year quarter for Payables in the past five years was fiscal Q3 2023, with growth of 468.4%; the weakest was fiscal Q3 2025, with a decline of 81.0%.
- According to Business Quant data, Payables for the three prior fiscal quarters was $1.35 million (Q4 2026), $1.86 million (Q3 2026) and $717,488 (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Alzamend Neuro | 5.73 Mn | -9.73 Mn | - | 2.74 Mn |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 2.74 Mn |
| Apr 30, 2026 | 1.35 Mn |
| Jan 31, 2026 | 1.86 Mn |
| Oct 31, 2025 | 717,488.00 |
| Jul 31, 2025 | 983,311.00 |
| Apr 30, 2025 | 634,761.00 |
| Jan 31, 2025 | 725,851.00 |
| Oct 31, 2024 | 1.25 Mn |
| Jul 31, 2024 | 2.88 Mn |
| Apr 30, 2024 | 3.23 Mn |
| Jan 31, 2024 | 3.83 Mn |
| Oct 31, 2023 | 3.67 Mn |
| Jul 31, 2023 | 2.74 Mn |
| Apr 30, 2023 | 2.87 Mn |
| Jan 31, 2023 | 2.64 Mn |
| Oct 31, 2022 | 648,119.00 |
| Jul 31, 2022 | 1.03 Mn |
| Apr 30, 2022 | 1.16 Mn |
| Jan 31, 2022 | 464,895.00 |
| Oct 31, 2021 | 1.13 Mn |
Alzamend Neuro Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ALZN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();